Insmed (INSM) Assets Average (2011 - 2026)
Insmed (INSM) posted Assets Average of $2.1 billion for Q2 2026, down 3.73% on a QoQ basis from $2.2 billion in Q1 2026, and down 2.43% year-over-year from $2.1 billion in Q2 2025.
Analysis
Insmed (INSM) Assets Average (2011 - 2026) Analysis & Trends
Insmed has reported Assets Average for 16 years, with the latest figure at $2.1 billion in Q2 2026.
- On a quarterly basis, Assets Average fell 2.43% year-over-year to $2.1 billion in Q2 2026; TTM through Jun 2026 was $2.1 billion, a 2.43% decrease from a year earlier, with the FY2025 full-year figure at $2.1 billion, up 27.86% from the prior year.
- Assets Average was $2.1 billion for Q2 2026 at Insmed, down from $2.2 billion in the prior quarter.
- The five-year high for Assets Average was $2.4 billion in Q3 2025, with the low at $1.0 billion in Q3 2022.
- Average Assets Average over 5 years is $1.7 billion, with a median of $1.5 billion recorded in 2023.
- The sharpest annual moves came in 2022 and 2024: Assets Average surged 61.02% in 2022, then dropped 21.59% in 2024.
- Over 5 years, Assets Average stood at $1.3 billion in 2022, then grew by 0.13% to $1.3 billion in 2023, then jumped by 53.62% to $2.0 billion in 2024, then rose by 13.42% to $2.3 billion in 2025, then declined by 9.66% to $2.1 billion in 2026.
- The last three Assets Average figures came in at $2.1 billion (Q2 2026), $2.2 billion (Q1 2026), and $2.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 94.07 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 52.82 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 26.95 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 41.30 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 11.22 Bn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 30.78 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 2.09 Bn |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn | 24.16 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.09 Bn |
| Mar 31, 2026 | 2.17 Bn |
| Dec 31, 2025 | 2.31 Bn |
| Sep 30, 2025 | 2.42 Bn |
| Jun 30, 2025 | 2.14 Bn |
| Mar 31, 2025 | 1.91 Bn |
| Dec 31, 2024 | 2.04 Bn |
| Sep 30, 2024 | 1.93 Bn |
| Jun 30, 2024 | 1.48 Bn |
| Mar 31, 2024 | 1.24 Bn |
| Dec 31, 2023 | 1.33 Bn |
| Sep 30, 2023 | 1.38 Bn |
| Jun 30, 2023 | 1.48 Bn |
| Mar 31, 2023 | 1.59 Bn |
| Dec 31, 2022 | 1.33 Bn |
| Sep 30, 2022 | 1.02 Bn |
| Jun 30, 2022 | 1.10 Bn |
| Mar 31, 2022 | 1.20 Bn |
| Dec 31, 2021 | 1.28 Bn |
| Sep 30, 2021 | 1.27 Bn |